跳至主要内容
临床试验/ACTRN12619001521112
ACTRN12619001521112尚未招募2 期

ignocaine versus opioids as analgesia in myocardial infarction - assessment of efficacy and safety

Ambulance Victoria0 个研究点目标入组 300 人开始时间: 2019年11月4日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult age greater than or equal to 18 years or older
  • 12-lead ECG consistent with STEMI
  • Chest pain greater than or equal to 5/10
  • Transfer to a primary PCI centre in metropolitan Melbourne

排除标准

  • No IV inserted
  • Opioids administered prior to randomisation
  • Known hypersensitivity to opioids or lignocaine
  • HR < 50 bpm
  • Out of hospital cardiac arrest (chest compressions or defibrillation) or cardiogenic shock (SBP<90mmHg)
  • Regular opioid use
  • Past history of epilepsy
  • Stage IV or V chronic kidney disease
  • Known cirrhotic liver disease
  • Patient dependent on others for activities of daily living

研究者

相似试验